Dr. Amina's Lens | A Public Health Doctor's Take on the Global Femtech Frontier

Medicine, systems, and technology.
A column exploring the current state of women's health from a structural perspective.

Why am I doing this series?

For a long time,
we have treated changes related to women's bodies and sexuality
as somewhat of a "taboo," avoiding direct discussion.

However, new technologies are now emerging from this very space that we once chose to "not see."

New devices and services are gradually making the bodily changes that previously relied solely on sensation, into something "visible."

At the same time, there are still unaddressed gaps between these innovations and existing systems and culture.

From a public health perspective, I want to keep asking, not "What's trending?" but
"What does society truly need?"

And I want to carefully examine
how the new options emerging around the world
have the power to change our lives, our future,
and the way women of the next generation live.

Dr. Amina's Lens is a series that introduces future options while traversing medicine, policy, markets, and culture, and provides perspectives for understanding the underlying structures.

Beyond the trends.
We will explore future possibilities by deciphering the underlying structures.

Explore more

CEO, fermata Inc. / Doctor of Public Health

Dr. Amina SUGIMOTO

After completing her master's degree at the University of Tokyo, she obtained her PhD in Public Health from the London School of Hygiene & Tropical Medicine. She specializes in healthcare systems and women's health policy.

In 2019, she founded fermata, leading the social implementation of femtech/women's health tech in Japan.

Through the creation of "Femtech Fes!" and collaborations with government agencies, she is expanding women's health as a "standard option."

Her efforts have been recognized with the "Woman of Courage" award from the US government and her selection as "Nikkei Woman of the Year 2024," earning her high praise both domestically and internationally.